Top

Published in:

16-01-2023 | Fibromatosis | Review Article

Desmoid-type fibromatosis: imaging features and course

Authors: Miho Okuda, Kotaro Yoshida, Satoshi Kobayashi, Toshifumi Gabata

Published in: Skeletal Radiology | Issue 7/2023

Abstract

Desmoid-type fibromatosis (DF) is a soft tissue tumor characterized by infiltrative growth and a tendency toward local recurrence, while it exhibits self-limiting behavior and shows spontaneous regression. With its unpredictable behavior, a change in treatment strategies from initial surgery to nonsurgical management has been proposed, and active surveillance is currently widely chosen as the initial treatment strategy for DF. We reviewed the imaging features of DF regarding its clinical course, focusing on regression cases, postoperative cases, and imaging changes after systemic treatment.

Bansal A, Goyal S, Goyal A, Jana M. WHO classification of soft tissue tumours 2020: An update and simplified approach for radiologists. Eur J Radiol. 2021;143: 109937.PubMed

Colombo C, Gronchi A. Desmoid-type fibromatosis: what works best? European journal of cancer (Oxford. England. 1990;2009(45 Suppl 1):466–7.

Braschi-Amirfarzan M, Keraliya AR, Krajewski KM, Tirumani SH, Shinagare AB, Hornick JL, et al. Role of imaging in management of desmoid-type fibromatosis: a primer for radiologists. Radiographics. 2016;36(3):767–82.PubMed

Rock MG, Pritchard DJ, Reiman HM, Soule EH, Brewster RC. Extra-abdominal desmoid tumors. J Bone Joint Surg Am. 1984;66(9):1369–74.PubMed

Lewis JJ, Boland PJ, Leung DH, Woodruff JM, Brennan MF. The enigma of desmoid tumors. Ann Surg. 1999; 229(6):866–872; discussion 872–863.

Fiore M, Rimareix F, Mariani L, Domont J, Collini P, Le Péchoux C, et al. Desmoid-type fibromatosis: a front-line conservative approach to select patients for surgical treatment. Ann Surg Oncol. 2009;16(9):2587–93.PubMed

Burtenshaw SM, Cannell AJ, McAlister ED, Siddique S, Kandel R, Blackstein ME, et al. Toward observation as first-line management in abdominal desmoid tumors. Ann Surg Oncol. 2016;23(7):2212–9.PubMed

Peng PD, Hyder O, Mavros MN, Turley R, Groeschl R, Firoozmand A, et al. Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients. Ann Surg Oncol. 2012;19(13):4036–42.PubMedPubMedCentral

Nakayama T, Tsuboyama T, Toguchida J, Hosaka T, Nakamura T. Natural course of desmoid-type fibromatosis. J Orthop Sci. 2008;13(1):51–5.PubMed

10.

de Bruyns A, Li H, MacNeil A, Simmons C, Clarkson P, Goddard K, et al. Evolving practice patterns over two decades (1993–2013) in the management of desmoid-type fibromatosis in British Columbia. Clin Oncol (R Coll Radiol). 2020;32(4):e102–10.PubMed

11.

Crago AM, Denton B, Salas S, Dufresne A, Mezhir JJ, Hameed M, et al. A prognostic nomogram for prediction of recurrence in desmoid fibromatosis. Ann Surg. 2013;258(2):347–53.PubMed

12.

Shido Y, Nishida Y, Nakashima H, Katagiri H, Sugiura H, Yamada Y, et al. Surgical treatment for local control of extremity and trunk desmoid tumors. Arch Orthop Trauma Surg. 2009;129(7):929–33.PubMed

13.

Yao X, Corbett T, Gupta AA, Kandel RA, Verma S, Werier J, et al. A systematic review of active treatment options in patients with desmoid tumours. Curr Oncol. 2014;21(4):e613-629.PubMedPubMedCentral

14.

Wang J, Huang Y, Sun Y, Ge Y, Zhang M. Value of imaging findings in predicting post-operative recurrence of desmoid-type fibromatosis. Oncol Lett. 2020;19(1):869–75.PubMed

15.

Gronchi A, Colombo C, Le Péchoux C, Dei Tos AP, Le Cesne A, Marrari A, et al. Sporadic desmoid-type fibromatosis: a stepwise approach to a non-metastasising neoplasm–a position paper from the Italian and the French Sarcoma Group. Ann Oncol. 2014;25(3):578–83.PubMed

16.

Kasper B, Baumgarten C, Bonvalot S, Haas R, Haller F, Hohenberger P, et al. Management of sporadic desmoid-type fibromatosis: a European consensus approach based on patients' and professionals' expertise - a sarcoma patients EuroNet and European Organisation for Research and Treatment of Cancer/Soft Tissue and Bone Sarcoma Group initiative. European journal of cancer (Oxford, England : 1990). 2015; 51(2):127–136.

17.

Pignatti G, Barbanti-Bròdano G, Ferrari D, Gherlinzoni F, Bertoni F, Bacchini P, et al. Extraabdominal desmoid tumor. A study of 83 cases. Clin Orthop Relat Res. 2000(375):207–213.

18.

von Mehren M, Randall RL, Benjamin RS, Boles S, Bui MM, Conrad EU, 3rd, et al. Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016; 14(6):758–786.

19.

Bonvalot S. Sporadic abdominal wall desmoid: is it time to change our first-line approach? Ann Surg Oncol. 2014;21(7):2117–8.PubMed

20.

Kloeze J, van Veen M. Spontaneous regression of a sporadic intra-abdominal located desmoid-type fibromatosis. J Surg Case Rep. 2019; 2019(2):rjz037.

21.

Colombo C, Miceli R, Le Péchoux C, Palassini E, Honoré C, Stacchiotti S, et al. Sporadic extra abdominal wall desmoid-type fibromatosis: surgical resection can be safely limited to a minority of patients. European journal of cancer (Oxford, England : 1990). 2015; 51(2):186–192.

22.

Park JS, Nakache YP, Katz J, Boutin RD, Steffner RJ, Monjazeb AM, et al. Conservative management of desmoid tumors is safe and effective. J Surg Res. 2016;205(1):115–20.PubMed

23.

van Broekhoven DLM, Verschoor AJ, van Dalen T, Grünhagen DJ, den Bakker MA, Gelderblom H, et al. Outcome of nonsurgical management of extra-abdominal, trunk, and abdominal wall desmoid-type fibromatosis: a population-based study in the Netherlands. Sarcoma. 2018;2018:5982575.PubMedPubMedCentral

24.

Briand S, Barbier O, Biau D, Bertrand-Vasseur A, Larousserie F, Anract P, et al. Wait-and-see policy as a first-line management for extra-abdominal desmoid tumors. J Bone Joint Surg Am. 2014;96(8):631–8.PubMed

25.

Duhil de Bénazé G, Vigan M, Corradini N, Minard-Colin V, Marie-Cardine A, Verite C, et al. Functional analysis of young patients with desmoid-type fibromatosis: initial surveillance does not jeopardize long term quality of life. Eur J Surg Oncol. 2020; 46(7):1294–1300.

26.

Murphey MD, Ruble CM, Tyszko SM, Zbojniewicz AM, Potter BK, Miettinen M. From the archives of the AFIP: musculoskeletal fibromatoses: radiologic-pathologic correlation. Radiographics. 2009;29(7):2143–73.PubMed

27.

Lee JC, Thomas JM, Phillips S, Fisher C, Moskovic E. Aggressive fibromatosis: MRI features with pathologic correlation. AJR Am J Roentgenol. 2006;186(1):247–54.PubMed

28.

Rhim JH, Kim JH, Moon KC, Park SW, Sohn CH, Choi SH, et al. Desmoid-type fibromatosis in the head and neck: CT and MR imaging characteristics. Neuroradiology. 2013;55(3):351–9.PubMed

29.

Robbin MR, Murphey MD, Temple HT, Kransdorf MJ, Choi JJ. Imaging of musculoskeletal fibromatosis. Radiographics. 2001;21(3):585–600.PubMed

30.

Kransdorf MJ, Jelinek JS, Moser RP, Jr., Utz JA, Hudson TM, Neal J, et al. Magnetic resonance appearance of fibromatosis. A report of 14 cases and review of the literature. Skeletal Radiol. 1990; 19(7):495–499.

31.

Shinagare AB, Ramaiya NH, Jagannathan JP, Krajewski KM, Giardino AA, Butrynski JE, et al. A to Z of desmoid tumors. AJR Am J Roentgenol. 2011;197(6):W1008-1014.PubMed

32.

The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients. European journal of cancer (Oxford, England : 1990). 2020; 127:96–107.

33.

Basu S, Nair N, Banavali S. Uptake characteristics of fluorodeoxyglucose (FDG) in deep fibromatosis and abdominal desmoids: potential clinical role of FDG-PET in the management. Br J Radiol. 2007;80(957):750–6.PubMed

34.

Bonvalot S, Eldweny H, Haddad V, Rimareix F, Missenard G, Oberlin O, et al. Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients. Eur J Surg Oncol. 2008;34(4):462–8.PubMed

35.

Dalén BP, Geijer M, Kvist H, Bergh PM, Gunterberg BU. Clinical and imaging observations of desmoid tumors left without treatment. Acta Orthop. 2006;77(6):932–7.PubMed

36.

Garcia-Ortega DY, Martín-Tellez KS, Cuellar-Hubbe M, Martínez-Said H, Álvarez-Cano A, Brener-Chaoul M, et al. Desmoid-type fibromatosis. Cancers (Basel). 2020; 12(7).

37.

Kim Y, Rosario MS, Cho HS, Han I. Factors associated with disease stabilization of desmoid-type fibromatosis. Clin Orthop Surg. 2020;12(1):113–9.PubMedPubMedCentral

38.

Tanaka K, Yoshikawa R, Yanagi H, Gega M, Fujiwara Y, Hashimoto-Tamaoki T, et al. Regression of sporadic intra-abdominal desmoid tumour following administration of non-steroidal anti-inflammatory drug. World J Surg Oncol. 2008;6:17.PubMedPubMedCentral

39.

Sueishi T, Arizono T, Nishida K, Hamada T, Inokuchi A. A case of spontaneous regression of recurrent desmoid tumor originating from the internal obturator muscle after delivery. World J Oncol. 2016;7(4):75–80.PubMedPubMedCentral

40.

Castellazzi G, Vanel D, Le Cesne A, Le Pechoux C, Caillet H, Perona F, et al. Can the MRI signal of aggressive fibromatosis be used to predict its behavior? Eur J Radiol. 2009;69(2):222–9.PubMed

41.

Cassidy MR, Lefkowitz RA, Long N, Qin LX, Kirane A, Sbaity E, et al. Association of MRI T2 signal intensity with desmoid tumor progression during active observation: a retrospective cohort study. Ann Surg. 2020;271(4):748–55.PubMed

42.

Vandevenne JE, De Schepper AM, De Beuckeleer L, Van Marck E, Aparisi F, Bloem JL, et al. New concepts in understanding evolution of desmoid tumors: MR imaging of 30 lesions. Eur Radiol. 1997;7(7):1013–9.PubMed

43.

Gondim Teixeira PA, Biouichi H, Abou Arab W, Rios M, Sirveaux F, Hossu G, et al. Evidence-based MR imaging follow-up strategy for desmoid-type fibromatosis. Eur Radiol. 2020;30(2):895–902.PubMed

44.

Mahnashi Y, Alotaibi AS, Aldakhail M, Alshahrani A. Desmoid tumor at the gastrointestinal anastomosis after a one-anastomosis gastric bypass (mini-gastric bypass): a case report. J Surg Case Rep. 2020; 2020(1):rjz411.

45.

Samejima J, Ito H, Yokose T, Nagashima T. Desmoid-type fibromatosis arising from thoracotomy incision. Clin Case Rep. 2020;8(2):389–90.PubMed

46.

Ohtake S, Namura K, Fujikawa A, Sawada T, Ohta J, Moriyama M, et al. A case of abdominal wall desmoid tumor after radical nephrectomy for renal cancer. Hinyokika Kiyo. 2015;61(9):353–7.PubMed

47.

Kim PS, Han DS, Han HS, Bang HY. Intra-abdominal fibromatosis after gastrectomy for gastric cancer. Ann Surg Treat Res. 2014;87(6):331–5.PubMedPubMedCentral

48.

Nałęcz A, Dębski K, Dobosz M, Krauze M. Desmoid tumor of the mesentery in a patient after restorative proctocolectomy as a result of familial adenomatous polyposis - case reports. Pol Przegl Chir. 2018;90(3):53–8.PubMed

49.

Mori T, Yamada T, Ohba Y, Yoshimoto K, Ikeda K, Shiraishi K, et al. A case of desmoid-type fibromatosis arising after thoracotomy for lung cancer with a review of the english and Japanese literature. Ann Thorac Cardiovasc Surg. 2014;20(Suppl):465–9.PubMed

50.

Gupta R, Andley M, Talwar N, Kumar A. Sporadic desmoid-type fibromatosis occurring at laparoscopic trocar site: an unusual entity. Indian J Surg. 2018;80(3):275–7.PubMed

51.

Navin P, Lehrke HD, Schmitz JJ, Truty MJ, Moynagh MR. Desmoid fibromatosis mimicking metastatic recurrence after pancreatectomy for pancreatic adenocarcinoma. Mayo Clin Proc Innov Qual Outcomes. 2018;2(4):392–7.PubMedPubMedCentral

52.

Jiang D, He D, Hou Y, Lu W, Shi Y, Hu Q, et al. Subsequent intra-abdominal fibromatosis mimicking recurrent gastrointestinal stromal tumor. Diagn Pathol. 2013;8:125.PubMedPubMedCentral

53.

Kim JH, Ryu MH, Park YS, Kim HJ, Park H, Kang YK. Intra-abdominal desmoid tumors mimicking gastrointestinal stromal tumors - 8 cases: a case report. World J Gastroenterol. 2019;25(16):2010–8.PubMedPubMedCentral

54.

Fleetwood VA, Zielsdorf S, Eswaran S, Jakate S, Chan EY. Intra-abdominal desmoid tumor after liver transplantation: a case report. World J Transplant. 2014;4(2):148–52.PubMedPubMedCentral

55.

Okamura A, Takahashi T, Saikawa Y, Mayanagi S, Fukuda K, Nakamura R, et al. Intra-abdominal desmoid tumor mimicking gastric cancer recurrence: a case report. World J Surg Oncol. 2014;12:146.PubMedPubMedCentral

56.

Nakanishi K, Shida D, Tsukamoto S, Ochiai H, Mazaki J, Taniguchi H, et al. Multiple rapidly growing desmoid tumors that were difficult to distinguish from recurrence of rectal cancer. World J Surg Oncol. 2017;15(1):180.PubMedPubMedCentral

57.

Ono H, Hori K, Tashima L, Tsuruta T, Nakatsuka SI, Ito K. A case of retroperitoneal desmoid-type fibromatosis that involved the unilateral ureter after gynaecologic surgery. Int J Surg Case Rep. 2018;47:30–3.PubMedPubMedCentral

58.

Wang P, Zhou H, Zhou Z, Liang J. Mesenteric fibromatosis misdiagnosed with lymph node metastasis after successful laparoscopic right hemicolectomy: a report of two cases with review of literature. Onco Targets Ther. 2018;11:4811–6.PubMedPubMedCentral

59.

Chu Y, Guo Q, Wu D. Mesenteric fibromatosis after resection for gastrointestinal stromal tumor of stomach: a case report. Medicine (Baltimore). 2017;96(48): e8792.PubMed

60.

Rosa F, Martinetti C, Piscopo F, Buccicardi D, Schettini D, Neumaier CE, et al. Multimodality imaging features of desmoid tumors: a head-to-toe spectrum. Insights Imaging. 2020;11(1):103.PubMedPubMedCentral

61.

Sabharwal S, Ahlawat S, Levin AS, Meyer CF, Brooks E, Ligon J, et al. Desmoid tumor mimics local recurrence of extremity sarcoma on MRI. J Surg Oncol. 2020;121(8):1259–65.PubMed

62.

Lee JH, Song KD, Cha DI, Hyun SH. New intra-abdominal mass after operation for colorectal cancer: desmoid tumor versus peritoneal seeding. Abdom Radiol (NY). 2018;43(11):2923–7.PubMed

63.

Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, Dekkers OM, Hogendoorn PC, Vasen HF. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer. 2011;129(1):256–61.PubMed

64.

Burke AP, Sobin LH, Shekitka KM, Federspiel BH, Helwig EB. Intra-abdominal fibromatosis. A pathologic analysis of 130 tumors with comparison of clinical subgroups. Am J Surg Pathol. 1990; 14(4):335–341.

65.

Lotfi AM, Dozois RR, Gordon H, Hruska LS, Weiland LH, Carryer PW, et al. Mesenteric fibromatosis complicating familial adenomatous polyposis: predisposing factors and results of treatment. Int J Colorectal Dis. 1989;4(1):30–6.PubMed

66.

Libertini M, Mitra I, van der Graaf WTA, Miah AB, Judson I, Jones RL, et al. Aggressive fibromatosis response to tamoxifen: lack of correlation between MRI and symptomatic response. Clin Sarcoma Res. 2018;8:13.PubMedPubMedCentral

67.

Gondim Teixeira PA, Chanson A, Verhaeghe JL, Lecocq S, Louis M, Hossu G, et al. Correlation between tumor growth and hormonal therapy with MR signal characteristics of desmoid-type fibromatosis: a preliminary study. Diagn Interv Imaging. 2019;100(1):47–55.PubMed

68.

Ingley KM, Burtenshaw SM, Theobalds NC, White LM, Blackstein ME, Gladdy RA, et al. Clinical benefit of methotrexate plus vinorelbine chemotherapy for desmoid fibromatosis (DF) and correlation of treatment response with MRI. Cancer Med. 2019;8(11):5047–57.PubMedPubMedCentral

69.

Zanchetta E, Ciniselli CM, Bardelli A, Colombo C, Stacchiotti S, Baldi GG, et al. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis. Cancer Med. 2021;10(13):4356–65.PubMedPubMedCentral

70.

Zhu HC, Xu SX, Li XT, Guan Z, Li S, Sun YS. MRI T1 contrast-enhanced signal intensity is a prognostic indicator of imatinib therapy in Desmoid-type fibromatosis. Front Oncol. 2021;11: 615986.PubMedPubMedCentral

71.

Subhawong TK, Feister K, Sweet K, Alperin N, Kwon D, Rosenberg A, et al. MRI volumetrics and image texture analysis in assessing systemic treatment response in extra-abdominal desmoid fibromatosis. Radiol Imaging Cancer. 2021;3(4): e210016.PubMedPubMedCentral

72.

Kasper B, Dimitrakopoulou-Strauss A, Pilz LR, Strauss LG, Sachpekidis C, Hohenberger P. Positron emission tomography as a surrogate marker for evaluation of treatment response in patients with desmoid tumors under therapy with imatinib. Biomed Res Int. 2013;2013: 389672.PubMedPubMedCentral

Title: Desmoid-type fibromatosis: imaging features and course
Authors: Miho Okuda
Kotaro Yoshida
Satoshi Kobayashi
Toshifumi Gabata
Publication date: 16-01-2023
Publisher: Springer Berlin Heidelberg
Keyword: Fibromatosis
Published in: Skeletal Radiology / Issue 7/2023
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI: https://doi.org/10.1007/s00256-023-04275-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Desmoid-type fibromatosis: imaging features and course

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2023

Concurrent intraosseous cartilaginous lesions in patients with multiple osteochondromas identified on total-body MR imaging

Intravascular papillary hemangioendothelioma disguised as a peripheral sheath tumor of median nerve at the wrist: a case report and literature review

Original research: utilization of a convolutional neural network for automated detection of lytic spinal lesions on body CTs

Annual Meeting Abstracts of the German Society of Skeletal Radiology (DGMSR) 2023, May 5 – 6, Berlin/ Germany

Correction to: Weight‑bearing cone‑beam CT: the need for standardised acquisition protocols and measurements to fulfill high expectations—a review of the literature

Question—Multiple lesions of the skull in a 30-month-old girl